{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:17:42Z","timestamp":1761808662014},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,23]]},"DOI":"10.7759\/cureus.58852","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:14:55Z","timestamp":1713914095000},"source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Cryptococcosis Post Eculizumab Therapy: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Ibrahim","family":"Youssef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad S","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Manafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Akhondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0875-9","article-title":"Eculizumab: a review in generalized myasthenia gravis","volume":"78","author":"Dhillon S","year":"2018","unstructured":"Dhillon S. Eculizumab: a review in generalized myasthenia gravis. Drugs. 2018, 78:367-76. 10.1007\/s40265-018-0875-9","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock SJ","year":"2019","unstructured":"Pittock SJ, Berthele A, Fujihara K, et al.. Eculizumab in Aquaporin-4-positive neuromyelitis optica spectrum disorder. N Engl J Med. 2019, 381:614-25. 10.1056\/NEJMoa1900866","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.101013","article-title":"Management of infection in PNH patients treated with eculizumab or other complement inhibitors: unmet clinical needs","volume":"58","author":"Girmenia C","year":"2023","unstructured":"Girmenia C, Barcellini W, Bianchi P, et al.. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: unmet clinical needs. Blood Rev. 2023, 58:101013. 10.1016\/j.blre.2022.101013","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi SA","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, MacNeil JR. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020, 69:1-41. 10.15585\/mmwr.rr6909a1","journal-title":"MMWR Recomm Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/9.6.617","article-title":"Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans","volume":"9","author":"Lovchik JA","year":"1993","unstructured":"Lovchik JA, Lipscomb MF. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am J Respir Cell Mol Biol. 1993, 9:617-27. 10.1165\/ajrcmb\/9.6.617","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp170708","article-title":"Disseminated cryptococcosis associated with administration of eculizumab","volume":"75","author":"Clancy M","year":"2018","unstructured":"Clancy M, McGhan R, Gitomer J, Inocencio AM, Aldrich C, Iaderosa R, Stevens R. Disseminated cryptococcosis associated with administration of eculizumab. Am J Health Syst Pharm. 2018, 75:1018-22. 10.2146\/ajhp170708","journal-title":"Am J Health Syst Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad159","article-title":"Disseminated Cryptococcosis following eculizumab therapy: insight into pathogenesis","volume":"10","author":"Lortholary O","year":"2023","unstructured":"Lortholary O, El-Sissy C, Leporrier J, Sze Wah Wong S, Dannaoui E, Fremeaux-Bacchi V, Aimanianda V. Disseminated Cryptococcosis following eculizumab therapy: insight into pathogenesis. Open Forum Infect Dis. 2023, 10:ofad159. 10.1093\/ofid\/ofad159","journal-title":"Open Forum Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2021.12.004","article-title":"Cryptococcus gattii meningitis complicated by immune reconstitution inflammatory syndrome in an apparent immunocompetent host in Malaysia","volume":"35","author":"Chang CY","year":"2022","unstructured":"Chang CY, Mohd Shah SH, Lio JY, Bahari N, Radhakrishnan AP. Cryptococcus gattii meningitis complicated by immune reconstitution inflammatory syndrome in an apparent immunocompetent host in Malaysia. Med Mycol Case Rep. 2022, 35:1-4. 10.1016\/j.mmcr.2021.12.004","journal-title":"Med Mycol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2012.05.040","article-title":"Cryptococcus","volume":"22","author":"McDonald T","year":"2012","unstructured":"McDonald T, Wiesner DL, Nielsen K. Cryptococcus. Curr Biol. 2012, 22:R554-5. 10.1016\/j.cub.2012.05.040","journal-title":"Curr Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000973","article-title":"Microbe Profile: Cryptococcus neoformans species complex","volume":"166","author":"Bahn YS","year":"2020","unstructured":"Bahn YS, Sun S, Heitman J, Lin X. Microbe Profile: Cryptococcus neoformans species complex. Microbiology (Reading). 2020, 166:797-9. 10.1099\/mic.0.000973","journal-title":"Microbiology (Reading)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsyr.2004.04.003","article-title":"Cryptococcus neoformans capsule biosynthesis and regulation","volume":"4","author":"Janbon G","year":"2004","unstructured":"Janbon G. Cryptococcus neoformans capsule biosynthesis and regulation. FEMS Yeast Res. 2004, 4:765-71. 10.1016\/j.femsyr.2004.04.003","journal-title":"FEMS Yeast Res"},{"key":"ref12","article-title":"Activation of the complement system by the capsule of Cryptococcus neoformans","volume":"5","author":"Kozel TR","year":"1993","unstructured":"Kozel TR. Activation of the complement system by the capsule of Cryptococcus neoformans. Curr Top Med Mycol. 1993, 5:1-26.","journal-title":"Curr Top Med Mycol"},{"key":"ref13","article-title":"Role of IgG and complement component C5 in the initial course of experimental cryptococcosis","volume":"78","author":"Dromer F","year":"1989","unstructured":"Dromer F, Perronne C, Barge J, Vilde JL, Yeni P. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin Exp Immunol. 1989, 78:412-7.","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01119-08","article-title":"Role of complement in protection against Cryptococcus gattii infection","volume":"77","author":"Mershon KL","year":"2009","unstructured":"Mershon KL, Vasuthasawat A, Lawson GW, Morrison SL, Beenhouwer DO. Role of complement in protection against Cryptococcus gattii infection. Infect Immun. 2009, 77:1061-70. 10.1128\/IAI.01119-08","journal-title":"Infect Immun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244405-disseminated-cryptococcosis-post-eculizumab-therapy-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:14:59Z","timestamp":1713914099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244405-disseminated-cryptococcosis-post-eculizumab-therapy-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.58852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}